Literature DB >> 16401874

Progression of progressive multifocal leukoencephalopathy despite treatment with beta-interferon.

A Nath1, A Venkataramana, D S Reich, I Cortese, E O Major.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16401874     DOI： 10.1212/01.wnl.0000191322.93310.a1

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  8 in total

Review 1.  Progressive multifocal leukoencephalopathy: clinical and molecular aspects.

Authors:  Eleonora Tavazzi; Martyn K White; Kamel Khalili
Journal:  Rev Med Virol       Date:  2011-09-21       Impact factor: 6.989

2.  Interferon- alpha and - beta restrict polyomavirus JC replication in primary human fetal glial cells: implications for progressive multifocal leukoencephalopathy therapy.

Authors:  Juliene K G Co; Saguna Verma; Ulziijargal Gurjav; Laarni Sumibcay; Vivek R Nerurkar
Journal:  J Infect Dis       Date:  2007-07-20       Impact factor: 5.226

Review 3.  Progressive multifocal leukoencephalopathy and natalizumab.

Authors:  Kerstin Hellwig; Ralf Gold
Journal:  J Neurol       Date:  2011-06-07       Impact factor: 4.849

Review 4.  Progressive multifocal leukoencephalopathy and other forms of JC virus disease.

Authors:  Bruce J Brew; Nicholas W S Davies; Paola Cinque; David B Clifford; Avindra Nath
Journal:  Nat Rev Neurol       Date:  2010-12       Impact factor: 42.937

Review 5.  Progressive multifocal leukoencephalopathy in HIV-1 infection.

Authors:  Paola Cinque; Igor J Koralnik; Simonetta Gerevini; Jose M Miro; Richard W Price
Journal:  Lancet Infect Dis       Date:  2009-10       Impact factor: 25.071

6.  Serotonin receptor 2A blocker (risperidone) has no effect on human polyomavirus JC infection of primary human fetal glial cells.

Authors:  Moti L Chapagain; Laarni Sumibcay; Ulziijargal Gurjav; Pakieli H Kaufusi; Richard E Kast; Vivek R Nerurkar
Journal:  J Neurovirol       Date:  2008-11-12       Impact factor: 2.643

7.  Progressive multifocal leukoencephalopathy.

Authors:  Allen J Aksamit
Journal:  Curr Treat Options Neurol       Date:  2008-05       Impact factor: 3.598

8.  Disease-modifying drugs for multiple sclerosis and JC virus expression.

Authors:  Craig S Miller; Sidney A Houff; Jason Hopper; Robert J Danaher; Julie A Gurwell; Yushun Lin; Nubia Vega; Joseph R Berger
Journal:  J Neurovirol       Date:  2012-05-15       Impact factor: 2.643
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.